BlackRock, Inc. has filed an amendment to its Schedule 13G, revealing that it now holds a 10.2% ownership stake in Corteva, Inc. This significant investment underscores BlackRock's strategy in the agriculture production sector and highlights its commitment to enhancing its portfolio in this area.
Background
BlackRock, Inc. is a major player in the finance industry, specifically categorized under Security Brokers, Dealers & Flotation Companies (SIC 6211). The company is publicly traded on the New York Stock Exchange under the ticker symbol BLK. Recent filings include multiple Schedule 13G amendments and a quarterly report, showcasing BlackRock's active engagement in managing its investment portfolio.
What the Filing Says
The recent filing, dated November 4, 2026, indicates that BlackRock beneficially owns 68,055,049 shares of Corteva, Inc., with sole voting power over 63,751,079 shares. The filing states, "This Schedule 13G reflects the securities beneficially owned by certain business units of BlackRock, Inc. and its subsidiaries." This amendment marks the fifth update to their ownership status.
Impact
This ownership stake may affect various stakeholders, including investors, market analysts, and competitors within the agriculture production sector. BlackRock's significant investment could prompt other firms to reevaluate their positions in Corteva and the broader agricultural market.
What's Next
The filing does not say what happens next.
Read Next
Wassil Jim Reports Stock Transactions for Vaxcyte, Inc.
Cowan Elvia Reports Stock Transactions in SEC Filing
Saiki Julie Reports New Stock Transactions at Azora Therapeutics
Davidson Acquires Over 524,000 Shares of Azora Therapeutics
CBL & Associates Properties Announces New Stock Buyback Plan
Rothblatt amends Schedule 13G, reveals 4% stake in United Therapeutics









